Results 101 to 110 of about 2,798 (150)

Retrospective Analysis of Graft Loss Risk in Patients with BK Polyomavirus Associated Nephropathy in Relation to Rejection Status in a Multicentre Cohort with Regular Surveillance of BK Polyomavirus and Donor-Specific Antibody.

Am J Nephrol
Ma MK, Chan JF, Ho TL, Lam DC, Lee W, Sin HK, Szeto CC, Wong CK, Tang SC.   +8 more
europepmc   +1 more source

Multiple Retransplantations After BK Polyomavirus-Associated Metastatic Collecting Duct Carcinoma: Evidence for Protective BK-specific T-Cell Immunity. [PDF]

Transplantation
Hammer N, Khanna N, Haidar F, Hirsch HH.
europepmc   +1 more source

Urinary microbiome in renal transplant patients with BK polyomavirus reactivation. [PDF]

J Med Microbiol
Bates KA, Rivera VB, Glicklich D, Diflo T, Chaturvedi V, Nog R.   +5 more
europepmc   +1 more source

Research trends and hotspots in BK polyomavirus infection in kidney transplantation: A bibliometric analysis. [PDF]

Medicine (Baltimore)
Li Y, Duan Y, Fu J, Lu X, Zhao W.
europepmc   +1 more source

Serial Donor-derived Cell-free DNA Monitoring in a Kidney Transplant Recipient With Adenovirus Nephritis. [PDF]

Kidney Med
Xu EJ, Hirpara S, Kavcar AS, Jucha N, Sulejmani N, Pavlakis M, Rosen S, Pawar AS.   +7 more
europepmc   +1 more source

Lateral Flow Assay to detect CXCL10 as a diagnose-supporting biomarker for Polyomavirus-associated Nephropathy (PVAN) after kidney transplantation (KTx). [PDF]

Sci Rep
Hauch E, Seiler LK, Hoyer M, Scheffner I, Gwinner W, Lindner P, Blume C.   +6 more
europepmc   +1 more source

Management of BK Polyomavirus in a Kidney Transplant Recipient With Primary Myelofibrosis on JAK-2 Inhibition - A Case Report and Literature Review. [PDF]

Can J Kidney Health Dis
Bywater L, Gill J, Nicholl D.
europepmc   +1 more source

Cytomegalovirus and BK polyomavirus in belatacept-treated kidney transplant recipients: a systematic review and meta-analysis. [PDF]

BMC Nephrol
Tawhari I, Yamani F, Alotaibi M, El Hennawy H, Tawhari M, Alqahtani M, Asiri K.   +6 more
europepmc   +1 more source

Outcomes After 4-Week Course of Sofosbuvir/Velpatasvir Therapy in Hepatitis C Seronegative Recipients of Kidneys From Hepatitis C Viremic Deceased Donors. [PDF]

Clin Transplant
Kummangal BA, Hack M, Selvam SA, Connelly C, Smith J, Pandav J, Mattos A, Do L, Ziolko A, McKenna D, Rehman S.   +10 more
europepmc   +1 more source